ASN: Elderly with chronic kidney disease benefit from SGLT2 inhibitors
Sodium-glucose cotransporter 2 (SGLT2) inhibitors show significant benefits for adults aged 80 years and older with chronic kidney disease (CKD), according to a study presented at Kidney Week, the annual meeting of the American ...
Nov 2, 2026
0
180









